Literature DB >> 27006507

Reply to Curry and Coombs: Benzoic acid is formed predominantly from the benzoyl ester hydrolysis in the presence of cocaine hydrolase.

Fang Zheng1, Chang-Guo Zhan1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 27006507      PMCID： PMC4839422          DOI： 10.1073/pnas.1602720113

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  10 in total

1.  Characterization of a high-activity mutant of human butyrylcholinesterase against (-)-cocaine.

Authors:  Wenchao Yang; Liu Xue; Lei Fang; Xi Chen; Chang-Guo Zhan
Journal:  Chem Biol Interact       Date:  2010-01-11       Impact factor: 5.192

2.  Kinetic characterization of high-activity mutants of human butyrylcholinesterase for the cocaine metabolite norcocaine.

Authors:  Max Zhan; Shurong Hou; Chang-Guo Zhan; Fang Zheng
Journal:  Biochem J       Date:  2014-01-01       Impact factor: 3.857

3.  Benzoic acid is not the only important product of accelerated metabolism of cocaine.

Authors:  Stephen H Curry; Susan E Coombs
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-22       Impact factor: 11.205

4.  Computational redesign of human butyrylcholinesterase for anticocaine medication.

Authors:  Yongmei Pan; Daquan Gao; Wenchao Yang; Hoon Cho; Guangfu Yang; Hsin-Hsiung Tai; Chang-Guo Zhan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-07       Impact factor: 11.205

5.  Long-acting cocaine hydrolase for addiction therapy.

Authors:  Xiabin Chen; Liu Xue; Shurong Hou; Zhenyu Jin; Ting Zhang; Fang Zheng; Chang-Guo Zhan
Journal:  Proc Natl Acad Sci U S A       Date:  2015-12-28       Impact factor: 11.205

6.  A randomized, double-blind, placebo-controlled trial of RBP-8000 in cocaine abusers: pharmacokinetic profile of rbp-8000 and cocaine and effects of RBP-8000 on cocaine-induced physiological effects.

Authors:  Azmi F Nasser; Paul J Fudala; Bo Zheng; Yongzhen Liu; Christian Heidbreder
Journal:  J Addict Dis       Date:  2014

7.  Assessment of Pharmacokinetic and Pharmacodynamic Interactions Between Albumin-Fused Mutated Butyrylcholinesterase and Intravenously Administered Cocaine in Recreational Cocaine Users.

Authors:  Megan J Shram; Orit Cohen-Barak; Bijan Chakraborty; Merav Bassan; Kerri A Schoedel; Hussein Hallak; Eli Eyal; Sivan Weiss; Yossi Gilgun-Serki; Yossi Gilgun; Edward M Sellers; Janice Faulknor; Ofer Spiegelstein
Journal:  J Clin Psychopharmacol       Date:  2015-08       Impact factor: 3.153

8.  Thermostable variants of cocaine esterase for long-time protection against cocaine toxicity.

Authors:  Daquan Gao; Diwahar L Narasimhan; Joanne Macdonald; Remy Brim; Mei-Chuan Ko; Donald W Landry; James H Woods; Roger K Sunahara; Chang-Guo Zhan
Journal:  Mol Pharmacol       Date:  2008-11-05       Impact factor: 4.436

9.  Safety, pharmacokinetics, and pharmacodynamics of TV-1380, a novel mutated butyrylcholinesterase treatment for cocaine addiction, after single and multiple intramuscular injections in healthy subjects.

Authors:  Orit Cohen-Barak; Jacqueline Wildeman; Jeroen van de Wetering; Judith Hettinga; Petra Schuilenga-Hut; Aviva Gross; Shane Clark; Merav Bassan; Yossi Gilgun-Sherki; Boaz Mendzelevski; Ofer Spiegelstein
Journal:  J Clin Pharmacol       Date:  2015-01-12       Impact factor: 3.126

10.  Modeling of pharmacokinetics of cocaine in human reveals the feasibility for development of enzyme therapies for drugs of abuse.

Authors:  Fang Zheng; Chang-Guo Zhan
Journal:  PLoS Comput Biol       Date:  2012-07-26       Impact factor: 4.475
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.